#ResearchNeverStops

EVT Execute

Our services

EVT Innovate

Our R&D initiatives

Action Plan

The data-driven R&D Autobahn to Cures

Science Pool

Evotec's new scientific content hub

Jobs

What you can contribute

IR & ESG

How you can participate

Highlights

Evotec Capital Markets Day - Paradigm Shift in Biologics

2 November 2022 in Redmond / Seattle

Click here for webcast recording

DDup 13

PanHunter: Evotec's next-generation multi-omics data analysis platform

Just - Evotec Biologics' J.POD® wins CPhI Pharma Award 2022

DDup 12

Evotec`s 3D cell model platform

News View all news

Evotec announces agreement with Janssen to develop immune-based therapies

Hamburg, Germany, 26 Jan 2023

Evotec SE announced today that the Company has entered into a strategic collaboration and licence agreement with Janssen Biotech, Inc....

Read more

Evotec-partner Sernova provides update on development of iPSC-derived cell therapy for diabetes

London, ON, Canada, 10 Jan 2023

Sernova Corp., a clinical-stage company and leader in cell therapeutics, announced today that significant progress has been achieved in...

Read more

IR & ESG Events View all events

2 February2023

8 February2023

Evotec Governance Roadshow Venue: Virtual
Organisers: Evotec SE

9 February2023

Hamburger Investoren Tag HIT Venue: Hamburg
Organisers: Montega AG

Company Presentation

Download our Company Presentation

January 2023

Download

TOP